Data as of Sep 17
| -0.03 / -0.29%|
The 4 analysts offering 12-month price forecasts for Veracyte Inc have a median target of 22.00, with a high estimate of 25.00 and a low estimate of 20.00. The median estimate represents a +111.13% increase from the last price of 10.42.
The current consensus among 5 polled investment analysts is to Buy stock in Veracyte Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.